NUOVA PROSPETTIVA TERAPEUTICA NELL'ENURESI LA DESMOPRESSINA (DDAVP)

Translated title of the contribution: Desmopressin (DDAVP): A new solution to the treatment of enuresis

G. Segni, E. Salvaggio, D. Parenti, L. Cataldi, C. Auriti, A. Rossodivita, M. Fano

Research output: Contribution to journalArticlepeer-review

Abstract

The therapeutic effectiveness of desmopressin (DDAVP) was evaluated in 40 children. The protocol consisted of 20 and 30 mcg administrations in a pattern including observation, placebo, and treatment for 6 weeks. There was a prompt response to treatment, and success was achieved in nearly 90% of cases. This, coupled with the tolerability of DDAVP and the complete absence of side-effects, indicates that it is both effective and safe for the management of enuresis.

Translated title of the contributionDesmopressin (DDAVP): A new solution to the treatment of enuresis
Original languageItalian
Pages (from-to)45-52
Number of pages8
JournalMinerva Pediatrica
Volume34
Issue number1-2
Publication statusPublished - 1982

ASJC Scopus subject areas

  • Pediatrics, Perinatology, and Child Health

Fingerprint Dive into the research topics of 'Desmopressin (DDAVP): A new solution to the treatment of enuresis'. Together they form a unique fingerprint.

Cite this